Trials / Unknown
UnknownNCT03225235
Prospective Evaluation of Hypofractionated Stereotactic RT Using CyberKnife for Patients With Prostate Cancer
Prospective Evaluation of Hypofractionated Stereotactic RT (SBRT) Using CyberKnife for Patients With Low and Intermediate Risk of Progression Prostate Cancer.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 600 (estimated)
- Sponsor
- The Greater Poland Cancer Centre · Academic / Other
- Sex
- Male
- Age
- 40 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose of study is to evaluate hypofractionated stereotactic radiotherapy (SBRT) using CyberKnife for Patients with low and intermediate risk of progression prostate cancer.
Detailed description
Evaluation of the usefulness expression of selected proteins (PTEN, SMAD4, Cyclin D1, SPP1) as prognostic and predictive factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | SBRT | hypofractionated stereotactic radiotherapy (SBRT) using CyberKnife for Patients With Low and Intermediate Risk of Progression Prostate Cancer |
Timeline
- Start date
- 2013-08-26
- Primary completion
- 2020-12-01
- Completion
- 2025-08-01
- First posted
- 2017-07-21
- Last updated
- 2020-02-05
Locations
1 site across 1 country: Poland
Source: ClinicalTrials.gov record NCT03225235. Inclusion in this directory is not an endorsement.